logo
Select company
Select metric
-26829.57%Operating Cash Flow Margin
VS
Market
1
Sector
3
Industry
6
History
-
$ 2.29Close
$ 1.11 - $ 4.65 52-Week Range
Ticker Information

Ticker

SABS

Company Name

SAB BIOTHERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

SAB BIOTHERAPEUTICS INC - Operating Cash Flow Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

SABS - OCF % Historical data
DateNet Cash Flow - OperationsOperating Cash Flow MarginRevenues
6/30/2025$ -30.77M-26829.57%$ 114.7K
3/31/2025$ -31.34M-8294.42%$ 377.83K
12/31/2024$ -34.29M-2593.15%$ 1.32M
9/30/2024$ -38.21M-2525.68%$ 1.51M
6/30/2024$ -37.08M-1333.86%$ 2.78M
3/31/2024$ -34.26M-1316.59%$ 2.6M
12/31/2023$ -25.12M-1121.91%$ 2.24M
9/30/2023$ -11.46M-279.77%$ 4.09M
6/30/2023$ -14.46M-225.36%$ 6.42M
3/31/2023$ -14.77M-116.48%$ 12.68M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • SAB BIOTHERAPEUTICS INC's latest trailing twelve months (TTM) OCF % stands at 6.17%.
  • Over the past 5 years, SAB BIOTHERAPEUTICS INC's average OCF % has been -3203.15%.
  • The median OCF % for SAB BIOTHERAPEUTICS INC during this period was -700.84%
  • SAB BIOTHERAPEUTICS INC reached its highest OCF % over the past 5 years at 6.17%.
  • The lowest OCF % recorded by SAB BIOTHERAPEUTICS INC in the same timeframe -26829.57%

SAB BIOTHERAPEUTICS INC's OCF % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

OCF % Benchmarks
CompanyOCF %
ABP : ABPRO HOLDINGS INC -4326.23%AIM : AIM IMMUNOTECH INC -9055.37%AIMD : AINOS INC -4432.56%PFSA : PROFUSA INC -1891.88%KAPA : KAIROS PHARMA LTD -PPCB : PROPANC BIOPHARMA INC -QTTB : Q32 BIO INC -CVKD : CADRENAL THERAPEUTICS INC -VIVS : VIVOSIM LABS INC -7336.62%LIXT : LIXTE BIOTECHNOLOGY HOLDINGS INC -

Definition of Operating Cash Flow Margin

[Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
CF - Operations / Revenues
(=) OCF %
OCF % for SAB BIOTHERAPEUTICS INC is calculated as follows: CF - Operations [ $ 3.76M ] / Revenues [ $ 60.88M ]
(=) OCF % [ 6.17% ]

SABS - Operating Cash Flow Margin, Last 5 years

-26829.57%

Minimum

Jun 30, 2025

6.17%

Maximum

Dec 31, 2021

-3203.15%

Average

-700.84%

Median

OCF % Benchmark Analysis

The chart above depicts the distribution of OCF % for companies in the Total Stock Market. The average OCF % of the companies is 14.35% with a standard deviation of 21.14%.
The following table provides additional summary stats:
OCF % in the Market:
filtered constituents3.25K
min-57.27%
max78.12%
average14.35%
median12.67%
std21.14%